The effects of naltrexone in active Crohn's disease

Trial Profile

The effects of naltrexone in active Crohn's disease

Phase of Trial: Phase II

Latest Information Update: 31 May 2017

At a glance

  • Drugs Naltrexone (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 May 2017 According to an Immune Therapeutics media release, The company is ready to submit a New Drug Application (NDA) to the Directorate of Pharmacy and Medicines. The application will include results of four phase II clinical trials and one bridging trial clinical trial.
    • 01 May 2010 Results presented at 2010 Digestive Disease Week.
    • 11 Dec 2009 Status changed from active, no longer recruiting to completed as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top